28^th Global Obesity Meeting

Obesity in Patients with COVID-19

Obesity has been identified as a significant risk factor for severe outcomes in patients with COVID-19. Studies have shown that individuals with obesity are more likely to experience complications such as hospitalization, intensive care unit admission, and mechanical ventilation compared to those with lower body mass index (BMI). Obesity is associated with impaired immune function, chronic inflammation, and underlying health conditions like diabetes and cardiovascular disease, which can exacerbate COVID-19 severity. The increased prevalence of obesity worldwide has raised concerns about its impact on public health responses to infectious diseases like COVID-19. Managing obesity through weight loss, lifestyle modifications, and medical interventions is crucial for reducing the risk of severe COVID-19 outcomes and improving overall health outcomes in affected individuals.